000 | 01052 a2200301 4500 | ||
---|---|---|---|
005 | 20250511181932.0 | ||
264 | 0 | _c19920602 | |
008 | 199206s 0 0 eng d | ||
022 | _a0002-9173 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrunt, E M | |
245 | 0 | 0 |
_aImmunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver. _h[electronic resource] |
260 |
_bAmerican journal of clinical pathology _cMay 1992 |
||
300 |
_aS53-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenoma, Bile Duct _xmetabolism |
650 | 0 | 4 | _aBiomarkers, Tumor |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Diseases _xmetabolism |
650 | 0 | 4 |
_aLiver Neoplasms _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
650 | 0 | 4 | _aReceptor, ErbB-2 |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aStaining and Labeling |
700 | 1 | _aSwanson, P E | |
773 | 0 |
_tAmerican journal of clinical pathology _gvol. 97 _gno. 5 Suppl 1 _gp. S53-61 |
|
999 |
_c1380713 _d1380713 |